Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failureJoseph H Chewning, Hugo Castro-Malaspina, Ann Jakubowski, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Precision Editing of Cyclophilin A Generates Cyclosporine and Voclosporin Resistant Cellular TherapiesHolly Wobma, Francesca Alvarez Calderon, Jiayi Dong, et al.
Transplantation and Cellular Therapy|September 23, 2025
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell TransplantationJessica S Little, Kyle M Hebert, Donna S Neuberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2017
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid MalignanciesBarbara Spitzer, Ann A Jakubowski, Esperanza B Papadopoulos, et al.
Blood Advances|September 22, 2021
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasmOriana Miltiadous, Kseniya Petrova-Drus, Shipra Kaicker, et al.
Blood|December 6, 2011
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantationEkaterina Doubrovina, Banu Oflaz-Sozmen, Susan E Prockop, et al.
Blood|November 8, 2014
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantationDoris M Ponce, Patrick Hilden, Christen Mumaw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host diseaseJenna D Goldberg, Alex Linker, Deborah Kuk, et al.
ACR Open Rheumatology|September 9, 2023
Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic ArthritisHolly Wobma, Ronny Bachrach, Joseph Farrell, et al.
Blood|June 12, 2025
A single dose of a CD137 antibody-drug conjugate protects nonhuman primate allogeneic HCT recipients against acute GVHDUlrike Gerdemann, Kyle Kimler, Matthew R Warren, et al.
Pageof 7